<DrugInformationSummary id="CDR0000808197"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about sirolimus protein-bound particles
         and a collection of links to more information about the use of 
         this drug, research results, and ongoing clinical trials.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/sirolimus-protein-bound-particles">Sirolimus Protein-Bound Particles</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000583541">sirolimus protein-bound nanoparticles</TerminologyLink><GlossaryLink ref="CDR0000806962">sirolimus protein-bound particles</GlossaryLink><USBrandNames><USBrandName>Fyarro</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>sih-ROH-lih-mus PROH-teen-bownd PAR-tih-kulz</TermPronunciation><MediaLink ref="CDR0000808516" type="audio/mpeg" alt="" language="en" id="_4"/><MediaLink ref="CDR0000808517" type="audio/mpeg" alt="" language="es" id="_5"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f9bb784-53e2-46f9-a65d-1c6c2a230eaf&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Sirolimus Protein-Bound Particles</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f9bb784-53e2-46f9-a65d-1c6c2a230eaf&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Sirolimus protein-bound particles
         are approved to treat adults with:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000782531" dictionary="Cancer.gov" audience="Patient">Perivascular epithelioid cell tumors</GlossaryTermRef></Strong> that are <GlossaryTermRef href="CDR0000044058" dictionary="Cancer.gov" audience="Patient">metastatic</GlossaryTermRef> or cannot be removed by <GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">surgery</GlossaryTermRef>.</ListItem>
   </ItemizedList>
  <Para id="_4">Sirolimus protein-bound particles are a form of <GlossaryTermRef href="CDR0000045513" dictionary="Cancer.gov" audience="Patient">sirolimus</GlossaryTermRef> contained in <GlossaryTermRef href="CDR0000653131" dictionary="Cancer.gov" audience="Patient">nanoparticles</GlossaryTermRef> (very tiny particles of protein). The drug is also called nanoparticle albumin-bound <GlossaryTermRef href="CDR0000285947" dictionary="Cancer.gov" audience="Patient">rapamycin</GlossaryTermRef>. This form may work better than other forms of sirolimus and have fewer side effects.</Para><Para id="_5">Sirolimus protein-bound particles
         are also being studied in the treatment of other types of
         <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef>.</Para>
 </Section><Section id="_About"><Title>More About Sirolimus Protein-Bound Particles</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/583541">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.5">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a622006.html">Sirolimus Protein-Bound Particles</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.6"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.7">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C74065">Find Clinical Trials for Sirolimus Protein-bound Nanoparticles</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2022-02-17</DateFirstPublished><DateLastModified>2022-06-08</DateLastModified></DrugInformationSummary>
